Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study

Jessica Kaufman, Katie Attwell, Jane Tuckerman, Jacinta O'Sullivan, Saad B. Omer, Julie Leask, Annette Regan, Helen Marshall, Katherine J. Lee, Tom Snelling, Kirsten Perrett, Kerrie Wiley, Michelle L. Giles, Margie Danchin

Research output: Contribution to journalArticle

Abstract

Background: Pregnancy is a critical time for vaccine decision-making, but coverage remains suboptimal for maternal influenza (45–60%) and pertussis vaccination (65–80%) in Australia. The multi-component P3-MumBubVax intervention has been designed for Australian midwives to optimise antenatal vaccine discussions and improve maternal and childhood vaccine uptake. A pilot study was conducted to assess intervention feasibility and acceptability. Methods: P3-MumBubVax includes components at three levels: 1. Practice ('vaccine champions'; stickers to prompt and record vaccine discussions/delivery); 2. Provider (website with vaccine communication training; learning exercise; fact sheets; links to child vaccination resources); 3. Parent (SMS reminders; website; fact sheets). Midwives and pregnant women 18–22 weeks gestation were recruited at the Royal Women's Hospital, Melbourne. Post-intervention online surveys assessed intervention feasibility, implementation, acceptability and impact on vaccine uptake. Results: Twenty-five midwives and 62 pregnant women were recruited and 19/25 midwives completed training. Surveys were returned by 18/25 midwives and 56/62 women. 14/18 midwives reported using the sticker prompts, 10/18 reported using or referring to the website, and 11/18 reported using the fact sheets. 48/56 pregnant women (86%) reported discussing influenza and 46/56 (82%) discussed pertussis vaccines with their midwives. These conversations were reported to be short (1–3 min) for 48/56 women (87%). All midwives were satisfied with the intervention and 17/18 reported feeling more confident discussing vaccines following the intervention. Women were very satisfied with SMS content (50/56; 94%) and timing (49/55; 89%), and with their vaccine discussions in general (34/56; 63%). However, 16/54 (30%) wanted more discussion about childhood vaccines. Self-reported maternal vaccine uptake was 82% (45/55) and 93% (51/55) for influenza and pertussis (baseline 2017–2018: 43% influenza, 60% pertussis) and 96% (50/52) of infants were fully vaccinated at 12 weeks. Discussion: The P3-MumBubVax intervention is feasible and acceptable in the Australian public antenatal setting. Further evaluation is required to determine effectiveness.

Original languageEnglish
Pages (from-to)4024-4031
Number of pages8
JournalVaccine
Volume38
Issue number24
DOIs
Publication statusPublished - 19 May 2020

Fingerprint Dive into the research topics of 'Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study'. Together they form a unique fingerprint.

  • Cite this

    Kaufman, J., Attwell, K., Tuckerman, J., O'Sullivan, J., Omer, S. B., Leask, J., Regan, A., Marshall, H., Lee, K. J., Snelling, T., Perrett, K., Wiley, K., Giles, M. L., & Danchin, M. (2020). Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study. Vaccine, 38(24), 4024-4031. https://doi.org/10.1016/j.vaccine.2020.04.010